For example, a meta-analysis showed that SOX2 is aberrantly expressed in head and neck cancer, and high SOX2 expression, in addition to high tumor grades, advanced TNM stages, lymph node metastasis and distant metastasis, predicts an unfavorable patient overall survival (OS)45. This evidence concerns the gene SOX2 and head and neck cancer.